Hu Sheng-Shou
Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
J Geriatr Cardiol. 2024 Jun 28;21(6):631-641. doi: 10.26599/1671-5411.2024.06.008.
The (2022) intricate landscape of cardiovascular health in China. In connection with the previous section, this sixth section of the report offers a comprehensive analysis of heart failure (HF) in China. HF is one of the most important cardiovascular disease in the 21 century. Its mortality is equivalent to that of cancer. It is an important public health problem that seriously affects the health of Chinese residents. In recent years, with the deepening of understanding, the change of treatment principles, the innovation of treatment methods and the update of treatment guidelines, the in-hospital mortality of HF patients has declined, and the long-term prognosis is also improving. However, there are still differences in the management level of HF among different hospitals in China. How to improve the standardized diagnosis and treatment level of HF in China remains an important challenge.
《2022年中国心血管健康的复杂状况》。与上一节相关,本报告的第六节对中国的心力衰竭(HF)进行了全面分析。心力衰竭是21世纪最重要的心血管疾病之一。其死亡率与癌症相当。它是一个严重影响中国居民健康的重要公共卫生问题。近年来,随着认识的深入、治疗原则的改变、治疗方法的创新以及治疗指南的更新,心力衰竭患者的院内死亡率有所下降,长期预后也在改善。然而,中国不同医院在心力衰竭管理水平上仍存在差异。如何提高中国心力衰竭的规范化诊疗水平仍然是一项重大挑战。